Roche launches AXELIOS 1, a transformative next-generation sequencing platform: Basel Tuesday, June 30, 2026, 10:00 Hrs [IST] Roche, a healthcare company, announced the launch of ...
We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...
When Roche previewed the Axelios technology in February, a Jefferies analyst called the next-generation sequencing platform the “greatest credible competitive threat in years.” ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
Roche Holding AG is looking to take a share of Illumina Inc.’s dominance in the gene sequencing market with the launch of Axelios 1, its next-generation sequencing (NGS) platform designed for accuracy ...
Next-generation sequencing (NGS) technologies have revolutionised phylogenetic analysis by enabling the acquisition of genome-scale data. Phylogenetic inference reconstructs evolutionary relationships ...
The U.S. Single-Cell Sequencing Market is projected to grow from USD 1.05 Billion in 2025 to USD 4.07 Billion by 2035, while ...
Privately held Element Biosciences said on Tuesday it had raised funds, including $175 million from longtime investor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results